Inventor
PROUTY CATHERINE P
US18 patents
⚠️ This page may combine multiple inventors who share the name “PROUTY CATHERINE P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IGNYTA INC
5 patentsUS9522902B2Dec 20, 2016
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC4 citations83
US9120778B2Sep 1, 2015
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC5 citations83
US9029538B2May 12, 2015
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC8 citations83
US10017496B2Jul 10, 2018
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC0 citations51
US9745283B2Aug 29, 2017
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC0 citations51
VERTEX PHARMA
4 patentsUS6162800ADec 19, 2000
N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
VERTEX PHARMA25 citations92
US6576614B1Jun 10, 2003
Peptide analogs as irreversible interleukin-1β protease inhibitors
VERTEX PHARMA7 citations73
US5985838ANov 16, 1999
Peptide analogs as irreversible interleukin-1β protease inhibitors
VERTEX PHARMA8 citations73
US6407080B2Jun 18, 2002
N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
VERTEX PHARMA3 citations62
ORTHO MCNEIL PHARM INC
3 patentsUS6362338B1Mar 26, 2002
Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
ORTHO MCNEIL PHARM INC1 citations52
US6063785AMay 16, 2000
Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
ORTHO MCNEIL PHARM INC1 citations52
US6780994B2Aug 24, 2004
Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
ORTHO MCNEIL PHARM INC0 citations42